Abbott posts higher quarterly revenue on strong medical device demand
Total revenue rose 7.1 per cent to US$11.4 billion
Add BT as a preferred source
[WASHINGTON] Abbott reported higher quarterly revenue on Wednesday (Oct 15), driven by strong demand for its medical devices including continuous glucose monitors and heart devices.
Investor confidence in medical device makers has climbed in recent quarters, underpinned by robust demand for surgical procedures, particularly among older adults.
Total revenue rose 7.1 per cent to US$11.4 billion.
On an adjusted basis, third-quarter profit per share of US$1.30, in line with analyst’s average estimate, according to data compiled by LSEG.
The company now expects annual adjusted profit between US$5.12 and US$5.18 per share, compared to its previous range of US$5.10 to US$5.20.
Its medical devices segment, which sells heart and diabetes care devices, posted sales of US$5.45 billion, beating estimates of US$5.34 billion. REUTERS
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Share with us your feedback on BT's products and services
TRENDING NOW
Yeoh Pei Xien: YTL’s third-gen scion with a pastor’s heart
UOB CEO’s youngest child Grant Wee turns burnout into a wellness business
Keppel H1 net profit drops 59% to S$155 million on impairments, M1 deal fallout; shares fall 4%
Singtel explores Nasdaq-SGX dual listing for data centre arm Nxera, local data centre Reit
